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screening or choose particular treatments.9 10 Vaccinat-
ing some people in a population may cause others (for
example, immunocompromised people) to become
sick through the spread of the vaccine virus or,
conversely, to remain well through the effect of herd
immunity.
The existence of collateral health effects and the
fact that each individual may be connected to
numerous others, including relatives, friends, neigh-
bours, and co-workers, implies developments in
research and policy. To explore such effects, new data-
sets and methods will be needed. Most prospective
cohort studies and randomised controlled trials today
include only individuals who are followed to observe
outcomes. Some social science and epidemiological
cohort studies do ask individuals about the health sta-
tus of their spouse or some other social contact, but
only a few (for example, the US health and retirement
survey) actually include the spouse or other social con-
tacts in the study cohort. Developing datasets with such
features and measurements is necessary to understand
fully collateral health effects. Collecting information
about the various contacts of people enrolled in
clinical trials or epidemiological studies may represent
an extension to study design similar to the extension in
the 1990s of including cost effectiveness analyses as a
standard feature of clinical trials.
Network phenomena are receiving increased atten-
tion in fields as diverse as engineering, biology, and
sociology,11 12 but they are also relevant to health and
medicine. Networks have emergent properties not
explained by the constituent parts and not present in
the parts. Understanding such properties requires
seeing whole groups of individuals and their
interconnections at once. The existence of social
networks means that people and events are interde-
pendent and that health and health care can transcend
the individual in ways that patients, doctors, policy
makers, and researchers should care about.
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Condoms and prevention of HIV
Are essential and effective, but additional methods are also needed
Promotion of condoms has been a mainstay ofHIV prevention policy. Over the past few years,however, the value and effectiveness of condoms
have increasingly been called into question. The grow-
ing “abstinence only” movement in the United States
questions the provision of condoms as part of the
policy and messaging of the US Agency for
International Development (USAID) and claims that
condoms have had little to do with the successes
achieved in reducing HIV in countries such as
Uganda.1–2 Senior officials in the Roman Catholic
Church also continue to argue about the morality of
condom use and dispute its efficacy.3
But what does the evidence tell us? A recent review
from the National Institutes for Health says that
condoms are protective against HIV infection,4 reduc-
ing the probability of HIV transmission per sex act by
as much as 95% and reducing the annual HIV
incidence in serodiscordant couples by 90-95% when
used consistently.5 However, the impact of inconsistent
use of condoms is less substantial: a meta-analysis
found that condom use of variable consistency among
serodiscordant couples reduced the annual HIV
incidence by 69%.6 This illustrates how the protection
provided by a condom is dependent both on its
efficacy against HIV transmission per sex act and the
consistency with which it is used. This is intuitive, yet
the consistency of condom use is less commonly
factored into scientific and policy debate.
Evidence from around the world highlights the
extent to which patterns of condom use are influenced
by the form of partnership in which they are being
used. Interventions can achieve substantial increases in
the use of condoms in commercial and casual sex part-
nerships. Several studies report high levels of condom
use after interventions in commercial sex.7–9 But even
in settings where HIV infection is widespread, the use
of condoms in primary partnerships remains low—
representative surveys of women in 13 African
countries found that fewer than 7% report condom use
in the last sex act with their regular partner.10 Surveys
of sex workers in Asia generally find that, although
many use condoms with their clients, fewer than 40%
report using condoms in their last non-commercial sex
act. Unless one partner knows they are HIV positive or
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feels substantially at risk, interventions generally have
limited success at achieving consistent use of condoms
in primary partnerships.10
These low levels of use are in part due to problems
of supply, access, and affordability: Shelton et al
estimated that 724 million condoms (an average of five
condoms per man) were distributed in sub-Saharan
Africa in 1999—excessively low for a region ravaged by
the HIV epidemic.11 The limited availability of
condoms reflects the failure of HIV prevention to go to
scale—the 2003 progress report from the joint United
Nations programme on HIV/AIDS (UNAIDS) on the
global response to the HIV/AIDS epidemic concluded
that only a fraction of people at risk of contracting HIV
have meaningful access to basic prevention services.12
Improvements in the supply and distribution of
condoms are likely to occur as initiatives to expand
HIV prevention and provide widespread antiretroviral
therapy are implemented.
Yet are a lack of supply and inadequate
programming the only problems? Surveys indicate
that even when people have access to condoms they
are still selective about which partnerships to use them
in.10 The low levels of condom use in primary partner-
ships reflect an important limitation of condoms. In
part because of the successes in promotion, the
condom is commonly conceptualised as something
that is used in less meaningful or more risky sex and is
therefore associated with a lack of intimacy and trust.
Sex workers report using condoms to distinguish
between commercial and non-commercial partners.
Practically too, their use may interrupt sex and, for
women, require negotiation with their male partner
who may resist use. Although female condoms
increase women’s options, they are costly and their use
may still require their partner’s consent. Both male and
female condoms are unsuitable for couples wanting to
conceive. These barriers and evidence on patterns of
condom use imply that, with increased investment and
programmatic effort, consistent use of condoms may
be substantially increased in commercial and casual
partnerships and between discordant couples. How-
ever, despite our best efforts, consistent use of
condoms in primary partnerships is likely to remain
difficult to achieve. This key failure of condoms needs
to be factored into future prevention planning.
Given the strengths and challenges of achieving
high levels of condom use we need to expand both
investment in the provision of male and female
condoms, and research into alternatives such as the
diaphragm and microbicides.w1 The experience of fam-
ily planning has taught us that additional options are
likely to increase overall levels of consistent use—the
same should be true for prevention of HIV.w2 Condoms
remain an essential weapon in the fight against HIV,
but the armoury needs to be expanded if we are to
enable women in regular partnerships to protect
themselves.
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